Trial Outcomes & Findings for Evaluation of Glistening, Visual Outcomes and General Safety 24 Months Post-IOL Implantation (NCT NCT07297719)
NCT ID: NCT07297719
Last Updated: 2026-08-19
Results Overview
Glistening count: Number of glistenings (=microvacuoles) in the illuminated field were counted by slit lamp examination at the study visit 24 months post IOL implantation of the study eye. Lower glistening counts indicate a better outcome (=fewer glistenings).
COMPLETED
33 participants
single study visit conducted 24 months after IOL implantation of the study eye
2026-08-19
Participant Flow
Participant milestones
| Measure |
IOL CT LUCIA 621P
Observational study conducted 24 months after cataract surgery and CT LUCIA 621P intraocular lens implantation; no new implantations of the CT LUCIA 621P IOL are performed as part of this study.
|
|---|---|
|
Overall Study
STARTED
|
33
|
|
Overall Study
COMPLETED
|
33
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Evaluation of Glistening, Visual Outcomes and General Safety 24 Months Post-IOL Implantation
Baseline characteristics by cohort
| Measure |
IOL CT LUCIA 621P
n=33 Participants
Observational study conducted 24 months after cataract surgery and CT LUCIA 621P intraocular lens implantation
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=298 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
4 Participants
n=298 Participants
|
|
Age, Categorical
>=65 years
|
29 Participants
n=298 Participants
|
|
Age, Continuous
|
73.2 Years
STANDARD_DEVIATION 7.0 • n=298 Participants
|
|
Sex: Female, Male
Female
|
20 Participants
n=298 Participants
|
|
Sex: Female, Male
Male
|
13 Participants
n=298 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=298 Participants
|
|
Race (NIH/OMB)
Asian
|
33 Participants
n=298 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=298 Participants
|
|
Race (NIH/OMB)
Black or African American
|
0 Participants
n=298 Participants
|
|
Race (NIH/OMB)
White
|
0 Participants
n=298 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=298 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=298 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
0 Participants
n=298 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
33 Participants
n=298 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=298 Participants
|
|
Race/Ethnicity, Customized
Nationality · Han Nationality
|
33 Participants
n=298 Participants
|
|
Race/Ethnicity, Customized
Nationality · Other Nationality
|
0 Participants
n=298 Participants
|
|
Region of Enrollment
China
|
33 Participants
n=298 Participants
|
|
Corrected distance visual acuity
|
0.54 logMAR
STANDARD_DEVIATION 0.21 • n=298 Participants
|
PRIMARY outcome
Timeframe: single study visit conducted 24 months after IOL implantation of the study eyeGlistening count: Number of glistenings (=microvacuoles) in the illuminated field were counted by slit lamp examination at the study visit 24 months post IOL implantation of the study eye. Lower glistening counts indicate a better outcome (=fewer glistenings).
Outcome measures
| Measure |
IOL CT LUCIA 621P
n=33 Participants
Observational study conducted 24 months after cataract surgery and CT LUCIA 621P intraocular lens implantation; no new implantations of the CT LUCIA 621P IOL are performed as part of this study.
|
|---|---|
|
Glistening Count
|
0 MV
Standard Deviation 0
|
PRIMARY outcome
Timeframe: single study visit conducted 24 months after IOL implantation of the study eyeGlistening density evaluation: Number of glistenings in the illuminated field were counted by slit lamp examination at the study visit 24 months post IOL implantation of the study eye. The number of glistenings were recorded and the density of microvacuoles per square millimeter (MV/mm²) was calculated. Lower glistening density values indicate better outcome (=fewer glistenings).
Outcome measures
| Measure |
IOL CT LUCIA 621P
n=33 Participants
Observational study conducted 24 months after cataract surgery and CT LUCIA 621P intraocular lens implantation; no new implantations of the CT LUCIA 621P IOL are performed as part of this study.
|
|---|---|
|
Glistening Density Evaluation
|
0 MV/mm²
Standard Deviation 0
|
PRIMARY outcome
Timeframe: single study visit conducted 24 months after IOL implantation of the study eyeGlistening grading (Miyata classification): At the 24-month post-IOL implantation visit, the number of glistenings/microvacuoles (MV) in the illuminated field of the study eye was counted by slit-lamp examination. Glistening density was expressed as microvacuoles per square millimeter (MV/mm²) and graded using the Miyata Glistening Density Grading Scale (grades 0-3), where the minimum glistening level corresponds to grade 0 (\<25 MV/mm²) and the maximum to grade 3 (101-200 MV/mm²).0 corresponds to \<25 MV/mm² and grade 3 to 101-200 MV/mm². Lower Miyata grades indicate a better outcome (=fewer glistenings).
Outcome measures
| Measure |
IOL CT LUCIA 621P
n=33 Participants
Observational study conducted 24 months after cataract surgery and CT LUCIA 621P intraocular lens implantation; no new implantations of the CT LUCIA 621P IOL are performed as part of this study.
|
|---|---|
|
Glistening Grading (Miyata Classification)
|
0 Scores on a scale
Standard Deviation 0
|
PRIMARY outcome
Timeframe: single study visit conducted 24 months after IOL implantation of the study eyeMonocular Corrected Distance Visual Acuity (CDVA) was assessed for each study eye using a standardized visual acuity chart under photopic conditions with the subject's best refractive correction in place. CDVA was recorded in logarithm of the Minimum Angle of Resolution (logMAR), with typical values ranging from about -0.3 (approximately 20/10 Snellen acuity) to 1.0 (approximately 20/200 Snellen acuity), where lower logMAR scores indicate better vision.
Outcome measures
| Measure |
IOL CT LUCIA 621P
n=33 Participants
Observational study conducted 24 months after cataract surgery and CT LUCIA 621P intraocular lens implantation; no new implantations of the CT LUCIA 621P IOL are performed as part of this study.
|
|---|---|
|
Monocular Corrected Distance Visual Acuity (CDVA)
|
0.043 logMAR
Standard Deviation 0.098
|
OTHER_PRE_SPECIFIED outcome
Timeframe: single study visit conducted 24 months after IOL implantation of the study eyeSubjective (manifest) refraction was performed under photopic conditions using standardized logarithmic visual acuity charts. For each study eye, manifest refraction was conducted to determine the best refractive correction. Sphere, cylinder, and axis were recorded, and spherical equivalent (SE) was calculated. SE values are reported in diopters (D). SE values closer to 0.00 D indicate a better refractive outcome (i.e., less residual myopia or hyperopia or astigmatism). An SE value within approximately ±0.50 D is generally considered a good refractive result.
Outcome measures
| Measure |
IOL CT LUCIA 621P
n=33 Participants
Observational study conducted 24 months after cataract surgery and CT LUCIA 621P intraocular lens implantation; no new implantations of the CT LUCIA 621P IOL are performed as part of this study.
|
|---|---|
|
Subjective Refraction (Spherical Equivalent)
|
-0.170 D (Diopter)
Standard Deviation 0.608
|
Adverse Events
IOL CT LUCIA 621P
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place
Restriction type: LTE60